We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.20 | 0.55% | 36.80 | 36.80 | 36.90 | 36.85 | 36.35 | 36.70 | 341,061 | 15:07:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 215.59 | 197.97M |
From Apr 2019 to Apr 2024
TIDMAPH
RNS Number : 9709S
Alliance Pharma PLC
29 June 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
Block Listing Six Monthly Return
Hot Features
Premium
Name of applicant: ALLIANCE PHARMA PLC
Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005
b) The Alliance Pharma plc Share Option Plan 2006
c) The Alliance Pharma plc Company Share Option Plan 2015
---------------------------------------------------------------
Period of return: From: 28 December 2017 To: 28 June 2018
----------------------- --------------------------- ------ --------------------------
Number of securities originally admitted at date of 25,000,000 ordinary shares of 1p each
admission: 28 June 2017
---------------------------------------------------------------
Balance of unallotted securities under schemes from a) 1,922,495
previous return: b) 19,105,243
c) 3,289,853
---------------------------------------------------------------
Plus: The amount by which the block schemes have a) Nil
been increased since the date of the last b) Nil
return (if any increase has been applied for): c) Nil
---------------------------------------------------------------
Less: Number of securities issued/allotted under a) 456,392
schemes during period: b) 1,689,202
c) 494,041
---------------------------------------------------------------
Equals: Balance under schemes not yet a) 1,466,103
issued/allotted at end of period: b) 17,416,041
c) 2,795,812
---------------------------------------------------------------
Name of contact: Chris Chrysanthou, Company Secretary
Telephone number of contact: Tel. +44 (0)1249 705166
-------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRLLFLRRDITFIT
(END) Dow Jones Newswires
June 29, 2018 02:01 ET (06:01 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
